Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




WEF Selects Transasia Bio-Medicals for Global Growth Company Award

By LabMedica International staff writers
Posted on 08 Jan 2015
Leading in vitro diagnostics (IVD) company Transasia Bio-Medicals Ltd. More...
(Mumbai, India) has been selected as “Global Growth Company-2014” by the World Economic Forum (WEF), comprising top global enterprises.

After a thorough evaluation process, Transasia Bio-Medicals was selected as one of the most dynamic and high-growth companies, and considered a trailblazer, shaper, and innovator committed to improving the state of the world. This award also recognizes the strength of Transasia’s leadership ability.

The pool of candidates for 2014 was exceptionally strong and diverse, making the process all the more difficult and challenging. Transasia was selected in part on the basis of being one of the fast-growing companies with potential for global economic leadership. The nominated Global Growth Companies (GGCs) represent a broad cross-section of industry sectors but share a track record of exceeding industry standards in revenue growth, promotion of innovative business practices, and demonstration of leadership in corporate citizenship. Transasia Bio-Medicals being commended as India’s top manufacturer and exporter of diagnostic products to over 100 countries has been happily reckoned in this group.

The award was presented on November 5, 2014, at the India Economic Summit held in New Delhi, organized by WEF along with the Confederation of Indian Industry (CII). The summit facilitated the meeting of the WEF’s global multi-stakeholder community with the new government, to together define and help shape the country’s next phase of transformation. It enabled high-level leaders from the government, civil society, and the business sector to participate in issue-based interaction and explore how to collectively shape policies for inclusive growth. India’s Finance and Defence Minister, Mr. Arun Jaitley, inaugurated the summit.

Transasia Bio-Medicals is synonymous with quality and precision. It strives to deliver holistic healthcare solutions, thus providing its patrons with technological advances backed by expertise and experience. The company’s global footprint and mission are not only being recognized in India but also globally, and it takes pride in this acknowledgement by the prestigious World Economic Forum.

Related Links:

Transasia Bio-Medicals



Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Hemodynamic System Monitor
OptoMonitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.